26E Stock Overview
Estia Health Limited provides residential aged care home services in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Estia Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.83 |
| 52 Week High | AU$1.83 |
| 52 Week Low | AU$1.19 |
| Beta | 0.96 |
| 1 Month Change | 2.81% |
| 3 Month Change | 3.39% |
| 1 Year Change | 53.78% |
| 3 Year Change | 69.44% |
| 5 Year Change | 41.86% |
| Change since IPO | -39.42% |
Recent News & Updates
Recent updates
Shareholder Returns
| 26E | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 3.7% | -2.0% |
| 1Y | 53.8% | -3.9% | -0.3% |
Return vs Industry: 26E exceeded the German Healthcare industry which returned 11.6% over the past year.
Return vs Market: 26E exceeded the German Market which returned 10% over the past year.
Price Volatility
| 26E volatility | |
|---|---|
| 26E Average Weekly Movement | 1.3% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 26E has not had significant price volatility in the past 3 months.
Volatility Over Time: 26E's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 8,220 | Sean Bilton | www.estiahealth.com.au |
Estia Health Limited provides residential aged care home services in Australia. It operates various residential aged care homes in New South Wales, Queensland, South Australia, and Victoria. The company was founded in 2005 and is headquartered in Sydney, Australia.
Estia Health Limited Fundamentals Summary
| 26E fundamental statistics | |
|---|---|
| Market cap | €496.21m |
| Earnings (TTM) | -€20.88m |
| Revenue (TTM) | €464.65m |
1.1x
P/S Ratio-23.8x
P/E RatioIs 26E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 26E income statement (TTM) | |
|---|---|
| Revenue | AU$754.30m |
| Cost of Revenue | AU$584.82m |
| Gross Profit | AU$169.48m |
| Other Expenses | AU$203.37m |
| Earnings | -AU$33.90m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 22.47% |
| Net Profit Margin | -4.49% |
| Debt/Equity Ratio | 14.0% |
How did 26E perform over the long term?
See historical performance and comparison